Cargando…
Analysis of recanalization of deep venous thrombosis: a comparative study of patients treated with warfarin vs. rivaroxaban
BACKGROUND: Deep venous thrombosis (DVT) strikes around ten million people worldwide every year and is associated with major complications including pulmonary embolism and post-thrombotic syndrome. Anticoagulation is the standard treatment, with administration of heparins, vitamin K antagonists, fon...
Autores principales: | Piati, Polyana Klomfass, Peres, Aline Krampe, de Andrade, Danielle Oliveira, Jorge, Mirela Andressa, Toregeani, Jeferson Freitas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV)
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636999/ https://www.ncbi.nlm.nih.gov/pubmed/31360152 http://dx.doi.org/10.1590/1677-5449.180111 |
Ejemplares similares
-
The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis
por: Fayyaz, Muniba, et al.
Publicado: (2019) -
Rivaroxaban vs. warfarin for the treatment and prevention of venous thromboembolism: A meta-analysis
por: Liu, Zhuang, et al.
Publicado: (2023) -
Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
por: Margolis, Jay M., et al.
Publicado: (2016) -
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for
Venous Thromboembolism
por: Coleman, Craig I., et al.
Publicado: (2018) -
Rivaroxaban for the treatment of cerebral venous thrombosis
por: Esmaeili, Sara, et al.
Publicado: (2021)